Acasti Pharma (TSXV:ACST) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Acasti Pharma Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Acasti Pharma's share price is C$0.57. Acasti Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.41. Hence, Acasti Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Acasti Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSXV:ACST's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.12
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Acasti Pharma's Cash Flow from Operations per share for the three months ended in Dec. 2023 was C$-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.41.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 45.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 42.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 22.80% per year.

During the past 13 years, Acasti Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.60% per year. The lowest was -24.80% per year. And the median was 14.70% per year.

Acasti Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Acasti Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acasti Pharma Price-to-Operating-Cash-Flow Chart

Acasti Pharma Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Acasti Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Acasti Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Acasti Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acasti Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acasti Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Acasti Pharma's Price-to-Operating-Cash-Flow falls into.

Acasti Pharma Price-to-Operating-Cash-Flow Calculation

Acasti Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.57	/	-0.409
	=

Acasti Pharma's Share Price of today is C$0.57.
Acasti Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.41.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Acasti Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Acasti Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Acasti Pharma (TSXV:ACST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ACST:USA A1P0:Germany

Address

3009 Boulevard de la Concorde East, Suite 102, Laval, QC, CAN, H7E 2B5

Website

https://www.acastipharma.com

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.